Press Interview, 100 Days German Hightech Agenda

On the occasion of the publication of the High-Tech Agenda 100 days ago and its launch by the federal government at the end of October, BIO Deutschland held a press conference with its new CEO, Roland Sackers, on November 7 to take stock of the agenda's goals and measures. A recent flash survey (see next item) showed that the mood among biotechnology companies remains stable compared to last year. A positive trend can be seen in the willingness to invest in research and development, while a rather negative trend can be seen in personnel planning. In order for the High-Tech Agenda to become a booster for the German biotech industry, federal ministries must now pool their resources and interlink them with EU initiatives, BIO Deutschland demands in the discussion. Only in this way can the measures be implemented and entrepreneurs in the industry be enabled to realize the full potential of biotechnology in Germany.